Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sjöström

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Proteomics|April 29, 2016
Cancer associated proteins in blood plasma: Determining normal variationMarkus Stenemo, Johan Teleman, Martin Sjöström, et al.
Journal of Clinical Pathology|July 16, 2015
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependentMartin Sjöström, Linda Hartman, Gabriella Honeth, et al.
Seminars in Radiation Oncology|June 18, 2023
Machine Learning & Molecular Radiation Tumor BiomarkersNicholas R Rydzewski, Kyle T Helzer, Matthew Bootsma, et al.
Molecular Oncology|September 18, 2020
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery: a long-term follow-up of the SweBCG91-RT randomised trialMartin Sjöström, Cynthia Veenstra, Erik Holmberg, et al.
Journal of Proteome Research|May 7, 2015
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker DiscoveryMartin Sjöström, Reto Ossola, Thomas Breslin, et al.
Plos One|April 18, 2020
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancerJulia Tutzauer, Martin Sjöström, Pär-Ola Bendahl, et al.
Breast Cancer Research : BCR|July 6, 2018
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictorsMartin Sjöström, Johan Staaf, Patrik Edén, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trialAxel Stenmark Tullberg, Martin Sjöström, Lena Tran, et al.
Clinical Proteomics|May 21, 2015
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastasesEmila Kurbasic, Martin Sjöström, Morten Krogh, et al.
Nature Communications|April 8, 2023
Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learningAnouk C de Jong, Alexandra Danyi, Job van Riet, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Proteomics|April 29, 2016
Cancer associated proteins in blood plasma: Determining normal variationMarkus Stenemo, Johan Teleman, Martin Sjöström, et al.
Journal of Clinical Pathology|July 16, 2015
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependentMartin Sjöström, Linda Hartman, Gabriella Honeth, et al.
Seminars in Radiation Oncology|June 18, 2023
Machine Learning & Molecular Radiation Tumor BiomarkersNicholas R Rydzewski, Kyle T Helzer, Matthew Bootsma, et al.
Molecular Oncology|September 18, 2020
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery: a long-term follow-up of the SweBCG91-RT randomised trialMartin Sjöström, Cynthia Veenstra, Erik Holmberg, et al.
Journal of Proteome Research|May 7, 2015
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker DiscoveryMartin Sjöström, Reto Ossola, Thomas Breslin, et al.
Plos One|April 18, 2020
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancerJulia Tutzauer, Martin Sjöström, Pär-Ola Bendahl, et al.
Breast Cancer Research : BCR|July 6, 2018
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictorsMartin Sjöström, Johan Staaf, Patrik Edén, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trialAxel Stenmark Tullberg, Martin Sjöström, Lena Tran, et al.
Clinical Proteomics|May 21, 2015
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastasesEmila Kurbasic, Martin Sjöström, Morten Krogh, et al.
Nature Communications|April 8, 2023
Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learningAnouk C de Jong, Alexandra Danyi, Job van Riet, et al.
Pageof 7